Xarelto (rivaroxaban) is a brand-name drug that helps treat or lower the risk of blood clots and certain other conditions. Xarelto comes as an oral tablet and suspension. The dosage can vary depending ...

"Providing adequate anticoagulation therapy for patients with AF undergoing cardio-version is important. With warfarin, patients will often move in and out of the therapeutic range for optimal ...

(Reuters) -Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to ...

Results of the highly anticipated ATLAS-ACS 2–TIMI 51 demonstrate that ACS patients receiving standard therapy, including dual antiplatelet therapy, may benefit from the addition of the factor Xa ...

Bayer and Johnson & Johnson’s Janssen Research & Development have acknowledged that their Xarelto ® (rivaroxaban) has failed a Phase III trial assessing the blockbuster anticoagulant in patients with ...

Complete Response Submitted to U.S. FDA on Bayer's Rivaroxaban for the Reduction of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome Berlin, Germany, September 7, 2012 – ...

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drugmakers ...

The quality and depth of clinical trials of the blood-thinner Xarelto could be a key issue when the first trials over the drug begin in Philadelphia courtrooms. With the first trial of more than 800 ...

The judge who oversaw the latest Xarelto trial in Philadelphia is asking the parties to produce more information about a social media post using the hashtag “#killinnazis,” which defendants say ...

Lawyers for patients who are suing two big drug makers who market a popular blood-clotting drug say the companies withheld important information from a letter published recently in a major medical ...

Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to those taking ...